Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

178
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
178
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

306
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
306

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sympathetic nervous system-mediated fibro-adipogenic progenitor mobilization drives stroke-related sarcopenia.

Cell discovery·2026
Same author

Fabricating Tunable Polyacrylamide Hydrogels To Study Matrix Stiffness Effects On Stem Leydig Cells.

Journal of visualized experiments : JoVE·2026
Same author

High Uric Acid Promotes Stem Leydig Cell Senescence by CCDC90B Mediates Mitochondrial Quality Control Imbalance.

Cell proliferation·2026
Same author

Intra-seafood strain diversity and temporal dynamics of Vibrio parahaemolyticus in a retail stall.

International journal of food microbiology·2026
Same author

Nestin promotes imatinib resistance in gastrointestinal stromal tumors by enhancing PINK1-dependent mitophagy.

Molecular medicine (Cambridge, Mass.)·2026
Same author

Synergistic Tuning of Structure and Active Phases in Zn-Mn Loaded Carbon Nanofiber Aerogel for High-Efficiency Desulfurization.

Angewandte Chemie (International ed. in English)·2026

Related Experiment Video

Updated: Jun 13, 2025

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.4K

DPP-4 Inhibitor Improved the Cognitive Function in Diabetic Rats.

Ying Hu1,2,3, Jiancheng Wang1,2,3, Jiao Wang1,2,3

  • 1Department of Endocrinology and Metabolism, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.

Journal of Healthcare Engineering
|September 16, 2024
PubMed
Summary

Saxagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, improved cognitive function in diabetic rats. This DPP-4 inhibitor reduced inflammation and tau phosphorylation, offering a potential treatment for diabetes-associated cognitive dysfunction.

More Related Videos

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

5.6K
An Ultrasonic Tool for Nerve Conduction Block in Diabetic Rat Models
10:27

An Ultrasonic Tool for Nerve Conduction Block in Diabetic Rat Models

Published on: October 20, 2017

7.3K

Related Experiment Videos

Last Updated: Jun 13, 2025

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.4K
Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

5.6K
An Ultrasonic Tool for Nerve Conduction Block in Diabetic Rat Models
10:27

An Ultrasonic Tool for Nerve Conduction Block in Diabetic Rat Models

Published on: October 20, 2017

7.3K

Area of Science:

  • Neuroscience
  • Endocrinology
  • Pharmacology

Background:

  • Diabetes-associated cognitive dysfunction is a significant global health concern.
  • Dipeptidyl peptidase-4 (DPP-4) inhibitors are commonly used for diabetes management.
  • The impact of DPP-4 inhibitors on cognitive function in diabetes requires further investigation.

Purpose of the Study:

  • To investigate the effect of the DPP-4 inhibitor saxagliptin on cognitive function in a diabetic rat model.
  • To elucidate the underlying mechanisms, including anti-inflammation and anti-tau phosphorylation, of saxagliptin's effects.

Main Methods:

  • Establishment of a diabetic rat model to induce cognitive dysfunction.
  • Evaluation of cognitive function using the Morris Water Maze Task.
  • Quantification of inflammatory markers (interleukin-1β, GFAP) and phosphorylated tau via Western blotting and immunohistochemistry.

Main Results:

  • Diabetes induced cognitive dysfunction in rats, as evidenced by performance in the Morris Water Maze Task.
  • Saxagliptin treatment ameliorated cognitive deficits in diabetic rats.
  • Saxagliptin demonstrated anti-inflammatory effects by reducing interleukin-1β and GFAP levels in the hippocampus.
  • Saxagliptin exhibited anti-tau phosphorylation effects.

Conclusions:

  • This study provides the first evidence that DPP-4 inhibitors, specifically saxagliptin, can alleviate cognitive dysfunction in diabetic rats.
  • Saxagliptin's therapeutic effects are mediated through anti-inflammatory and anti-tau phosphorylation mechanisms.
  • These findings suggest saxagliptin as a potential therapeutic agent for managing diabetes-associated cognitive dysfunction.